Incyte Corp. insider trading
In the last twelve months insiders at Incyte Corp. filed 28 open-market sales worth $25.5 million and 0 open-market purchases, on Form 4 with the SEC. The latest: Cagnoni Pablo J, President, Global Head of R&D, sold 9,233 shares at $120.50 on 15 September 2026, filed 17 September 2026.
| Traded | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 15 September 2026 | Cagnoni Pablo J | President, Global Head of R&D | Sale | 9,233 | $120.50 | $1.1 million | Form 4 |
| 15 September 2026 | Cagnoni Pablo J | President, Global Head of R&D | Sale | 13,985 | $120.49 | $1.7 million | Form 4 |
| 19 August 2026 | Cagnoni Pablo J | President, Global Head of R&D | Sale | 10,801 | $125.56 | $1.4 million | Form 4 |
| 12 August 2026 | Cagnoni Pablo J | President, Global Head of R&D | Sale | 10,803 | $120.04 | $1.3 million | Form 4 |
| 5 August 2026 | Cagnoni Pablo J | President, Global Head of R&D | Sale | 10,640 | $122.69 | $1.3 million | Form 4 |
| 5 August 2026 | Mayes Patrick A | EVP & Chief Scientific Officer | Sale | 2,207 | $123.99 | $273,646 | Form 4 |
| 3 August 2026 | Mayes Patrick A | EVP & Chief Scientific Officer | Sale | 6,055 | $120.43 | $729,204 | Form 4 |
| 31 July 2026 | Cagnoni Pablo J | President, Global Head of R&D | Sale | 15,888 | $119.70 | $1.9 million | Form 4 |
| 31 July 2026 | Mayes Patrick A | EVP & Chief Scientific Officer | Sale | 14,661 | $119.46 | $1.8 million | Form 4 |
| 31 July 2026 | Mayes Patrick A | EVP & Chief Scientific Officer | Sale | 5,332 | $119.42 | $636,747 | Form 4 |
| 31 July 2026 | Mayes Patrick A | EVP & Chief Scientific Officer | Sale | 2,187 | $119.47 | $261,281 | Form 4 |
| 31 July 2026 | Mayes Patrick A | EVP & Chief Scientific Officer | Sale | 6,171 | $119.43 | $737,003 | Form 4 |
| 31 July 2026 | Mayes Patrick A | EVP & Chief Scientific Officer | Sale | 4,695 | $119.39 | $560,536 | Form 4 |
| 31 July 2026 | Mayes Patrick A | EVP & Chief Scientific Officer | Sale | 2,864 | $119.40 | $341,962 | Form 4 |
| 31 July 2026 | Mayes Patrick A | EVP & Chief Scientific Officer | Sale | 1,643 | $119.51 | $196,355 | Form 4 |
| 31 July 2026 | Mayes Patrick A | EVP & Chief Scientific Officer | Sale | 1,642 | $119.38 | $196,022 | Form 4 |
| 31 July 2026 | Mayes Patrick A | EVP & Chief Scientific Officer | Sale | 85 | $122.19 | $10,386 | Form 4 |
| 31 July 2026 | Mayes Patrick A | EVP & Chief Scientific Officer | Sale | 326 | $121.69 | $39,671 | Form 4 |
| 31 July 2026 | Mayes Patrick A | EVP & Chief Scientific Officer | Sale | 2,293 | $119.41 | $273,807 | Form 4 |
| 16 July 2026 | Stein Steven H | CMO & Head of Late-Stage Dev. | Sale | 1,877 | $114.73 | $215,348 | Form 4 |
| 16 July 2026 | Issa Mohamed Khairie | EVP, Head of U.S. Commercial | Sale | 1,093 | $115.01 | $125,706 | Form 4 |
| 15 July 2026 | Stein Steven H | CMO & Head of Late-Stage Dev. | Sale | 28,237 | $113.05 | $3.2 million | Form 4 |
| 4 June 2026 | Tray Thomas | Principal Accounting Officer | Sale | 2,639 | $100.00 | $263,900 | Form 4 |
| 26 May 2026 | Tray Thomas | Principal Accounting Officer | Sale | 2,051 | $97.35 | $199,665 | Form 4 |
| 19 May 2026 | Clancy Paul J | Director | Sale | 15,000 | $94.93 | $1.4 million | Form 4 |
| 17 April 2026 | Cagnoni Pablo J | President, Global Head of R&D | Sale | 18,667 | $96.50 | $1.8 million | Form 4 |
| 17 March 2026 | Cagnoni Pablo J | President, R&D | Sale | 18,667 | $94.24 | $1.8 million | Form 4 |
| 19 February 2026 | Cagnoni Pablo J | President, R&D | Sale | 18,668 | $100.91 | $1.9 million | Form 4 |
Open-market purchases (code P) and sales (code S) only. Option exercises, grants, tax withholding and gifts are not shown. A filing with several lines appears once per line.
Source
Form 4 filings on EDGAR for Incyte Corp.: the company's filing index.
The same record on your computer
GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.